Thematic Description of Factors Linked with Extended-spectrum Beta-lactamase-producing Enterobacteriaceae in Humans

Overview

Journal Can Commun Dis Rep

Specialties Infectious Diseases
Public Health

Date 2024 Jul 18

PMID 39021380

Authors

Jamie Goltz

Carl Uhland

Sydney Pearce

Colleen Murphy

Carolee Carson

Jane Parmley

Affiliations

Soon will be listed here.

Abstract

Background: Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae are associated with serious antimicrobial-resistant infections in Canadians. Humans are exposed to ESBL-producing Enterobacteriaceae through many interconnected pathways. To better protect Canadians, it is important to generate an understanding of which sources and activities contribute most to ESBL exposure and infection pathways in Canada.

Objective: The aims of this scoping review were to thematically describe factors potentially associated with ESBL-producing Enterobacteriaceae colonization, carriage and/or infection in humans from countries with a very high human development index and describe the study characteristics.

Methods: Four databases (PubMed, CAB Direct, Web of Science, EBSCOhost) were searched to retrieve potentially relevant studies. Articles were screened for inclusion, and factors were identified, grouped thematically and described.

Results: The review identified 381 relevant articles. Factors were grouped into 13 themes: antimicrobial use, animals, comorbidities and symptoms, community, demographics, diet and substance use, health care, household, occupation, prior ESBL colonization/carriage/infection, residential care, travel, and other. The most common themes reported were demographics, health care, antibiotic use and comorbidities and symptoms. Most articles reported factors in hospital settings (86%) and evaluated factors for ESBL-producing Enterobacteriaceae infections (52%).

Conclusion: This scoping review provided valuable information about which factor themes have been well described (e.g., health care) and which have been explored less frequently (e.g., diet or animal contact). Themes identified spanned human, animal and environmental contexts and settings, supporting the need for a diversity of perspectives and a multisectoral approach to mitigating exposure to antimicrobial resistance.

References

Bezabih Y, Sabiiti W, Alamneh E, Bezabih A, Peterson G, Bezabhe W . The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community. J Antimicrob Chemother. 2020; 76(1):22-29. DOI: 10.1093/jac/dkaa399. View

Murphy C, Carson C, Smith B, Chapman B, Marrotte J, McCann M . Factors potentially linked with the occurrence of antimicrobial resistance in selected bacteria from cattle, chickens and pigs: A scoping review of publications for use in modelling of antimicrobial resistance (IAM.AMR Project). Zoonoses Public Health. 2018; 65(8):957-971. DOI: 10.1111/zph.12515. View

Furuya-Kanamori L, Stone J, Yakob L, Kirk M, Collignon P, Mills D . Risk factors for acquisition of multidrug-resistant Enterobacterales among international travellers: a synthesis of cumulative evidence. J Travel Med. 2019; 27(1). DOI: 10.1093/jtm/taz083. View

Karanika S, Karantanos T, Arvanitis M, Grigoras C, Mylonakis E . Fecal Colonization With Extended-spectrum Beta-lactamase-Producing Enterobacteriaceae and Risk Factors Among Healthy Individuals: A Systematic Review and Metaanalysis. Clin Infect Dis. 2016; 63(3):310-8. DOI: 10.1093/cid/ciw283. View

Hendrik T, Voor In t Holt A, Vos M . Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Klebsiella spp.: A Systematic Review and Meta-Analyses. PLoS One. 2015; 10(10):e0140754. PMC: 4617432. DOI: 10.1371/journal.pone.0140754. View

Riccio M, Verschuuren T, Conzelmann N, Martak D, Meunier A, Salamanca E . Household acquisition and transmission of extended-spectrum β-lactamase (ESBL) -producing Enterobacteriaceae after hospital discharge of ESBL-positive index patients. Clin Microbiol Infect. 2021; 27(9):1322-1329. DOI: 10.1016/j.cmi.2020.12.024. View

Flokas M, Detsis M, Alevizakos M, Mylonakis E . Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: A systematic review and meta-analysis. J Infect. 2016; 73(6):547-557. DOI: 10.1016/j.jinf.2016.07.014. View

Villafuerte D, Aliberti S, Soni N, Faverio P, Marcos P, Wunderink R . Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia. Respirology. 2019; 25(5):543-551. DOI: 10.1111/resp.13663. View

Detsis M, Karanika S, Mylonakis E . ICU Acquisition Rate, Risk Factors, and Clinical Significance of Digestive Tract Colonization With Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis. Crit Care Med. 2017; 45(4):705-714. DOI: 10.1097/CCM.0000000000002253. View

10.

Toombs-Ruane L, Benschop J, French N, Biggs P, Midwinter A, Marshall J . Carriage of Extended-Spectrum-Beta-Lactamase- and AmpC Beta-Lactamase-Producing Escherichia coli Strains from Humans and Pets in the Same Households. Appl Environ Microbiol. 2020; 86(24). PMC: 7688229. DOI: 10.1128/AEM.01613-20. View

11.

MacKinnon M, Sargeant J, Pearl D, Reid-Smith R, Carson C, Parmley E . Evaluation of the health and healthcare system burden due to antimicrobial-resistant Escherichia coli infections in humans: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2020; 9(1):200. PMC: 7726913. DOI: 10.1186/s13756-020-00863-x. View

12.

Mughini-Gras L, Dorado-Garcia A, van Duijkeren E, van den Bunt G, Dierikx C, Bonten M . Attributable sources of community-acquired carriage of Escherichia coli containing β-lactam antibiotic resistance genes: a population-based modelling study. Lancet Planet Health. 2019; 3(8):e357-e369. DOI: 10.1016/S2542-5196(19)30130-5. View

13.

Wuerz T, Kassim S, Atkins K . Acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) carriage after exposure to systemic antimicrobials during travel: Systematic review and meta-analysis. Travel Med Infect Dis. 2020; 37:101823. DOI: 10.1016/j.tmaid.2020.101823. View

14.

Hu Y, Ogyu A, Cowling B, Fukuda K, Pang H . Available evidence of antibiotic resistance from extended-spectrum β-lactamase-producing Enterobacteriaceae in paediatric patients in 20 countries: a systematic review and meta-analysis. Bull World Health Organ. 2019; 97(7):486-501B. PMC: 6593334. DOI: 10.2471/BLT.18.225698. View

15.

Alevizakos M, Karanika S, Detsis M, Mylonakis E . Colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis. Int J Antimicrob Agents. 2016; 48(6):647-654. DOI: 10.1016/j.ijantimicag.2016.08.021. View

16.

Paez A . Gray literature: An important resource in systematic reviews. J Evid Based Med. 2017; 10(3):233-240. DOI: 10.1111/jebm.12266. View

17.

Denisuik A, Karlowsky J, Adam H, Baxter M, Lagace-Wiens P, Mulvey M . Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016. J Antimicrob Chemother. 2019; 74(Suppl 4):iv64-iv71. DOI: 10.1093/jac/dkz289. View

18.

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

19.

Woerther P, Burdet C, Chachaty E, Andremont A . Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev. 2013; 26(4):744-58. PMC: 3811232. DOI: 10.1128/CMR.00023-13. View

20.

Pitout J, Nordmann P, Laupland K, Poirel L . Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother. 2005; 56(1):52-9. DOI: 10.1093/jac/dki166. View